Syndax Pharmaceuticals Inc (SNDX) Form 10-Q Quarterly Reports
Syndax Pharmaceuticals Inc (SNDX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SNDX
CIK: 1395937
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerThomas Kirkland
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000542 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001193125-26-332750 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001193125-26-332736 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-14 | 8-K | 0001193125-26-302608 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-08 | 4 | 0001193125-26-299803 | View SEC Doc Filr Page |
| 144 | 2026-07-08 | — | 144 Filing | 0001950047-26-006967 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-269694 | View SEC Doc Filr Page |
| 144 | 2026-06-12 | — | 144 Filing | 0001959173-26-004618 | View SEC Doc Filr Page |
| 144 | 2026-06-11 | — | 144 Filing | 0001959173-26-004566 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-10 | 8-K | 0001193125-26-266027 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-10 | 8-K | 0001193125-26-265852 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-04 | — | DEFA14A | 0001193125-26-256557 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-03 | 8-K | 0001193125-26-256458 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-06-01 | 4 | 0001193125-26-253603 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-06-01 | 4 | 0001193125-26-253601 | View SEC Doc Filr Page |
| 144 | 2026-06-01 | — | 144 Filing | 0001959173-26-004218 | View SEC Doc Filr Page |
| 144 | 2026-06-01 | — | 144 Filing | 0001959173-26-004216 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000919574-26-003472 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001193125-26-197892 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001193125-26-197877 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-04-30 | DEF 14A | 0001193125-26-197859 | View SEC Doc Filr Page |
| 10-Q | 2026-04-30 | 2026-03-31 | 10-Q | 0001193125-26-197154 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-30 | 8-K | 0001193125-26-197124 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-30 | — | SCHEDULE 13G Filing | 0002100119-26-001081 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-27 | — | SCHEDULE 13G/A Filing | 0000102909-26-002306 | View SEC Doc Filr Page |